IDEXX Laboratories, Inc. (IDXX)

Market Closed

17 Jul, 20:00

NASDAQ (NGS)

567. 44

-8.63

-1.4981%

45.44B Market Cap

55.21 P/E Ratio

- Div Yield

528,200 Volume

9.84 Eps

$ 576.07

Previous Close

Investors:

TJD

+305

Add Transaction

Day Range

561.15 579.4

Year Range

513.02 769.98

Want to track IDXX and more in your Portfolio? 🎯

Get Started For Free

Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?

IDEXX Laboratories, Inc. IDXX is expanding its global commercial capabilities to support continued growth in its CAG Diagnostics recurring revenue stream. The company's software ecosystem remains a key pillar of its value proposition.

Zacks | 3 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks | 3 months ago

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 3 months ago

IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It?

IDXX stock surges over the past year, fueled by strong diagnostics growth, innovation traction and expanding global demand in pet healthcare markets.

Zacks | 3 months ago

Idexx (IDXX) Upgraded to Buy: Here's Why

Idexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 3 months ago

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago